On December 14 and 15, the city of Hamburg once again became the epicenter of medical innovation, hosting the “BPH Innovation Forum 2023”.
This event, organized in detail by Olympus Medical System EMEA, once again brought together leading healthcare professionals and experts to explore the latest discoveries in the treatment of Benign Prostatic Hyperplasia (BPH).
The scientific program was designed to highlight the most recent innovations in the field of BPH, surgical modalities and technological advances that are transforming urological medicine. Participants had the opportunity to attend and be part of lectures and sessions with international experts, providing key information on the development of new techniques in the field.
Also, this year, i had the opportunity to participate as a speaker, talking about endoscopy in prostatic enucleation and cases performed with TFL, The Soltive superpulsed laser system from Olympus, giving statements about the learning line and sharing real-world data, giving statements about the learning line of this technique and sharing real-world data.
In addition, I was able to participate in discussions on the application and use of technologies in the treatment of Benign Prostatic Hyperplasia together with internationally renowned experts, with whom we shared knowledge and perspectives on the future of urology.
It is a privilege to be part of an event where there is a chance to interact with participants and share knowledge with leading professionals in the field, great people like Neil Barber, Silvia Secco, Rassler Jörg and Feras Al Jaadari. Exchanging ideas and strengthening the medical community fosters collaboration and the joint search for innovative solutions that makes us grow professionally.
Once again, I would like to thank Aynur Yaldiz, Hannah Reher and the entire Olympus Medical Systems EMEA team for leading these initiatives. Their dedication and vision have significantly contributed to the creation of an event where innovation and excellence continue to drive the evolution of medical care in the field of Benign Prostatic Hyperplasia.
